Riot Comments on Bitfarms’ Adoption of Shareholder-Unfriendly Poison Pill
Riot Platforms commented on Bitfarms' adoption of a shareholder rights plan, known as a 'Poison Pill'.
This plan prevents any shareholder from acquiring 15% or more of Bitfarms' shares without making a formal takeover bid. Riot criticized this move, stating it contradicts established legal and governance standards and reflects poor corporate governance.
CEO Jason Les highlighted that Riot had tried to privately engage with Bitfarms, urging the addition of independent directors and the resignation of Chairman Nicolas Bonta. Despite these efforts, Bitfarms implemented the Poison Pill with a lower-than-usual threshold, further entrenching its board.
Riot continues to advocate for better corporate governance at Bitfarms.
- Riot is actively pushing for better corporate governance at Bitfarms.
- Riot's efforts indicate a committed approach to shareholder value.
- The Poison Pill prevents shareholders from acquiring 15% or more of Bitfarms' shares without a formal takeover bid.
- Bitfarms' board disregarded Riot's proposal for two new independent directors.
- The Poison Pill's 15% trigger is below the customary 20% threshold, signaling potential governance issues.
- Riot's call for Chairman Nicolas Bonta's resignation was ignored, indicating poor responsiveness from Bitfarms' board.
Insights
Financial Analyst’s Perspective: The implementation of a ‘poison pill’ strategy by Bitfarms is significant because it’s a defensive tactic used to prevent hostile takeovers. This approach can have both short-term and long-term impacts on share prices. In the short term, it could stabilize the stock price by deterring potential acquirers from buying up shares. However, in the long term, it could be seen negatively by shareholders if they view the move as a way for the current management to entrench themselves without addressing underlying governance issues. This might lead to a lack of confidence and potentially a decline in share value, especially if shareholders perceive that there are better opportunities for growth and leadership outside the current management.
Moreover, the decision to set the poison pill threshold at 15%, which is lower than the customary 20% threshold, might raise red flags for investors as it deviates from standard practices recommended by proxy advisory firms. This could suggest that the board is more concerned with retaining control than with shareholder value, which might further erode trust.
From an investor’s perspective, this move underscores the importance of closely monitoring the governance practices of companies they invest in. Poor governance can often lead to suboptimal financial performance and misalignment between management and shareholder interests.
Corporate Governance Expert’s Perspective: Implementing a poison pill, particularly with a lower trigger threshold, signals an entrenched management that may be more concerned with preserving their positions than with the best interests of shareholders. The fact that Riot, a significant shareholder, had urged Bitfarms to consider new independent directors and address governance concerns through the chairman’s resignation reinforces this view. The move to implement the poison pill without shareholder consultation not only disregards their input but also contravenes best practices in corporate governance.
Good corporate governance entails transparency, accountability and engagement with shareholders. Actions that sideline shareholder involvement can lead to significant governance risks. For investors, the key takeaway is to be wary of companies that fail to uphold these principles, as it often correlates with negative outcomes for shareholder value and company performance.
Additionally, adhering to recommendations from leading proxy advisory firms like Institutional Shareholder Services Inc. and Glass, Lewis & Co. is generally considered a best practice. Deviating from these standards, as Bitfarms has done, could result in negative proxy advisor recommendations, which might influence institutional investor behavior against the company.
Poison Pill Comes Just Days After Riot Privately Urged Bitfarms to Consult with Riot and Other Large Shareholders on New Board Members and Stressed that Chairman Nicolas Bonta Must Resign to Address Corporate Governance Concerns
Jason Les, Chief Executive Officer of Riot, stated:
“We have attempted to privately engage with the Bitfarms Board and recently sent two letters urging constructive collaboration with us around the addition of at least two new directors who are fully independent of Bitfarms and Riot. Instead of engaging with us privately and in good faith, Bitfarms has responded by implementing an off-market Poison Pill with a trigger well below the customary
“This action further demonstrates the Bitfarms Board’s entrenchment and disregard for the perspectives of its shareholders, who clearly signaled their discontent less than two weeks ago when they voted out Company co-founder Emiliano Grodzki. In our most recent letter, we urged the Bitfarms Board to facilitate the resignation and removal of Chairman and interim CEO Nicolas Bonta, who has led the Bitfarms Board since 2018 and bears direct responsibility for its poor corporate governance practices, as a first step to address shareholders’ concerns.
“We will continue to push to address the serious corporate governance issues at Bitfarms and ensure that shareholders have a say on the Company’s path forward.”
About Riot Platforms, Inc.
Riot’s (NASDAQ: RIOT) vision is to be the world’s leading Bitcoin-driven infrastructure platform. Our mission is to positively impact the sectors, networks, and communities that we touch. We believe that the combination of an innovative spirit and strong community partnership allows the Company to achieve best-in-class execution and create successful outcomes.
Riot is a Bitcoin mining and digital infrastructure company focused on a vertically integrated strategy. The Company has Bitcoin mining operations in central
For more information, visit www.riotplatforms.com.
Non-Binding Proposal
Riot cautions Riot shareholders, Bitfarms shareholders and others considering trading in Riot securities or Bitfarms securities that the proposal Riot has made for a business combination transaction with Bitfarms is non-binding, does not constitute and should not be construed as an offer or intention to make an offer directly to Bitfarms shareholders, and there can be no assurance that any definitive offer will be made by Riot, that Bitfarms will accept any offer made by Riot, that any agreement will be entered into by Riot and Bitfarms or that the proposal or any other transaction will be approved or consummated. Riot does not undertake any obligation to provide any updates with respect to the proposed transaction, except as required by applicable law.
Cautionary Note Regarding Forward Looking Statements
Statements contained herein that are not historical facts constitute “forward-looking statements” and “forward-looking information” (together, “forward-looking statements”) within the meaning of applicable
No Offer or Solicitation
This press release is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer, or an intention to offer, to subscribe for or buy or an invitation to purchase or subscribe for any securities, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. Such an offer to purchase securities would only be made pursuant to a registration statement, prospectus, tender offer, takeover bid circular, management information circular or other regulatory filing filed by Riot with the SEC and available at www.sec.gov or filed with applicable Canadian securities regulatory authorities on SEDAR+ and available at www.sedarplus.ca. This press release is not intended to, and does not, solicit a proxy from any shareholder of Bitfarms. Such a solicitation of proxies would only be made pursuant to a proxy circular filed with applicable Canadian securities regulatory authorities on SEDAR+ and available at www.sedarplus.ca or pursuant to an exemption from the proxy solicitation rules under applicable Canadian securities law.
Important Information for Investors
This communication relates to, among other things, a proposal that Riot has made for a business combination transaction with Bitfarms. In furtherance of this proposal and subject to future developments, Riot (and, if applicable, Bitfarms) may file one or more registration statements, prospectuses, management information circulars, proxy statements, proxy circulars, tender offers, takeover bid circulars or other documents with the SEC and applicable Canadian securities regulatory authorities. This communication is not a substitute for any registration statement, prospectus, management information circular, proxy statement, proxy circular, tender offer, takeover bid circular or other document (collectively, “Regulatory Filings”) Riot and/or Bitfarms may file with the SEC and/or applicable Canadian securities regulatory authorities in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF RIOT AND BITFARMS ARE URGED TO READ EACH REGULATORY FILING WHEN AND IF FILED BY RIOT AND/OR BITFARMS WITH THE SEC AND/OR APPLICABLE CANADIAN SECURITIES REGULATORY AUTHORITIES CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT RIOT, BITFARMS, THE PROPOSED TRANSACTION AND RELATED MATTERS. Any proxy circular, takeover bid circular, management information circular, prospectus or other applicable Regulatory Filing (if and when filed) will be mailed to shareholders of Bitfarms (if and when required to be mailed by applicable law). Investors and security holders will be able to obtain free copies of Regulatory Filings (if and when available) and other documents filed by Riot with the SEC and available at www.sec.gov, and on the “Investor Relations” page of Riot’s corporate website, www.Riotplatforms.com. Investors and security holders will be able to obtain free copies of any documents filed with applicable Canadian securities regulatory authorities by Riot on SEDAR+ at www.sedarplus.ca, and on the “Investor Relations” page of Riot’s corporate website, www.Riotplatforms.com.
This communication is neither a solicitation of a proxy nor a substitute for any proxy statement or other filings that may be made with the SEC or Canadian securities regulatory authorities. Nonetheless, Riot and its directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. You can find information about Riot’s executive officers and directors in Riot’s Annual Report on Form 10‑K for the year ended December 31, 2023. Additional information regarding the interests of such potential participants will be included in one or more Regulatory Filings filed with the SEC and Canadian securities regulatory authorities if and when they become available. These documents (if and when available) may be obtained free of charge from the SEC’s website at www.sec.gov, on SEDAR+ at www.sedarplus.ca and by visiting the “Investor Relations” page of Riot’s corporate website, www.Riotplatforms.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240612057084/en/
Investor Contacts:
Phil McPherson
303-794-2000 ext. 110
IR@Riot.Inc
Okapi Partners
Bruce Goldfarb / Chuck Garske, (877) 285-5990
info@okapipartners.com
Media Contact:
Longacre Square Partners
Joe Germani / Dan Zacchei
jgermani@longacresquare.com / dzacchei@longacresquare.com
Source: Riot Platforms, Inc.
FAQ
What is the Poison Pill adopted by Bitfarms?
Why did Riot criticize Bitfarms' Poison Pill?
What did Riot propose to Bitfarms prior to the Poison Pill adoption?
What is the significance of the 15% trigger in Bitfarms' Poison Pill?